1. Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease 
Sripal Bangalore, MD, MHA, Rana Fayyad, PhD, Rachel Laskey, PhD, David A. DeMicco, PharmD, Prakash Deedwania, MD, John B. Kostis, MD, Franz H. Messerli, MD 
The American Journal of Medicine 
Volume 127, Issue 1, Pages e1 (January 2014)
DOI: /j.amjmed
Copyright © 2014 Elsevier Inc. Terms and Conditions

2. Figure 1
Apparent treatment-resistant hypertension and the risk of primary and secondary outcomes. aTRH = apparent treatment-resistant hypertension; CI = confidence interval; HR = hazard ratio.
The American Journal of Medicine  , e1DOI: ( /j.amjmed )
Copyright © 2014 Elsevier Inc. Terms and Conditions

3. Figure 2
(A) Cumulative incidence of primary outcome (death from coronary heart disease, nonfatal nonprocedure-related myocardial infarction, resuscitation after cardiac arrest, or fatal or nonfatal stroke) between patients with and without apparent treatment-resistant hypertension. (B) Cumulative incidence of coronary heart disease deaths between patients with and without apparent treatment-resistant hypertension. (C) Cumulative incidence of nonfatal myocardial infarction between patients with and without apparent treatment-resistant hypertension. aTRH = apparent treatment-resistant hypertension; CHD = coronary heart disease; HR = hazard ratio.
The American Journal of Medicine  , e1DOI: ( /j.amjmed )
Copyright © 2014 Elsevier Inc. Terms and Conditions

4. Figure 3
(A) Cumulative incidence of first major coronary events (death from coronary heart disease, nonfatal nonprocedure-related myocardial infarction, or resuscitation after cardiac arrest) between patients with and without apparent treatment-resistant hypertension. (B) Cumulative incidence of heart failure between patients with and without apparent treatment-resistant hypertension. (C) Cumulative incidence of all-cause mortality between patients with and without apparent treatment-resistant hypertension. (D) Cumulative incidence of any coronary events (revascularization procedure, procedure-related myocardial infarction, or documented angina) between patients with and without apparent treatment-resistant hypertension. (E) Cumulative incidence of any cardiovascular event between patients with and without apparent treatment-resistant hypertension. (F) Cumulative incidence of angina pectoris between patients with and without apparent treatment-resistant hypertension. (G) Cumulative incidence of coronary revascularization between patients with and without apparent treatment-resistant hypertension. aTRH = apparent treatment-resistant hypertension; HR = hazard ratio.
The American Journal of Medicine  , e1DOI: ( /j.amjmed )
Copyright © 2014 Elsevier Inc. Terms and Conditions

5. Figure 3
(A) Cumulative incidence of first major coronary events (death from coronary heart disease, nonfatal nonprocedure-related myocardial infarction, or resuscitation after cardiac arrest) between patients with and without apparent treatment-resistant hypertension. (B) Cumulative incidence of heart failure between patients with and without apparent treatment-resistant hypertension. (C) Cumulative incidence of all-cause mortality between patients with and without apparent treatment-resistant hypertension. (D) Cumulative incidence of any coronary events (revascularization procedure, procedure-related myocardial infarction, or documented angina) between patients with and without apparent treatment-resistant hypertension. (E) Cumulative incidence of any cardiovascular event between patients with and without apparent treatment-resistant hypertension. (F) Cumulative incidence of angina pectoris between patients with and without apparent treatment-resistant hypertension. (G) Cumulative incidence of coronary revascularization between patients with and without apparent treatment-resistant hypertension. aTRH = apparent treatment-resistant hypertension; HR = hazard ratio.
The American Journal of Medicine  , e1DOI: ( /j.amjmed )
Copyright © 2014 Elsevier Inc. Terms and Conditions